Investments
1Portfolio Exits
2Partners & Customers
6About Manhattan Scientifics
Manhattan Scientifics is located in New Mexico, New York, and Montreal. The company's goal is to advance and commercialize disruptive technologies to create profit for its shareholders. It is focused on commercializing disruptive technology in the fields of nanotechnology and nanomedicine.
Manhattan Scientifics Headquarters Location
405 Lexington Avenue The Chrysler Building 26th Floor
New York, New York, 10174,
United States
Latest Manhattan Scientifics News
Mar 17, 2022
March 17, 2022 08:41 AM Eastern Daylight Time NEW YORK--( BUSINESS WIRE )--Manhattan Scientifics Inc. ( OTCQB: MHTX ), announces positive early results from Imagion Biosystems Cancer Diagnostic human study. Imagion Biosystems Ltd. ( IBX.AX ) shares were up 46% trading 71 million shares. Manhattan Scientifics Inc., initially funded and is the current owner of more that 50 million shares of Imagion Biosystems Ltd. About Manhattan Scientifics, Inc. Manhattan Scientifics Inc. ( www.mhtx.com ) is focused on technology transfer and commercialization of transformative technologies. It has assisted incubating and financing four IPO’s working closely with Science Teams at the Los Alamos National Laboratory and the Sandia National Laboratory in New Mexico About Imagion Biosystems Imagion Biosystems ( www.imagionbiosystems.com )is developing a new non-radioactive and super-sensitive diagnostic imaging technology for very early detection of cancers. Imagion is listed on the Australian Stock Exchange ( ASX ). Forward-looking statement This press release contains forward-looking statements, which are subject to a number of risks, assumptions and uncertainties that could cause the Company's actual results to differ materially from those projected in such forward-looking statements. Management at Manhattan Scientifics believes that purchase of its shares should be considered to be at the high end of the risk spectrum. Forward-looking statements speak only as of the date made and are not guarantees of future performance. We undertake no obligation to publicly update or revise any forward-looking statements. Contacts
Manhattan Scientifics Investments
1 Investments
Manhattan Scientifics has made 1 investments. Their latest investment was in Novint Technologies as part of their Other Investors on .
Manhattan Scientifics Investments Activity
Date | Round | Company | Amount | New? | Co-Investors | Sources |
---|---|---|---|---|---|---|
Other Investors | Novint Technologies | Yes |
Date | |
---|---|
Round | Other Investors |
Company | Novint Technologies |
Amount | |
New? | Yes |
Co-Investors | |
Sources |
Manhattan Scientifics Portfolio Exits
2 Portfolio Exits
Manhattan Scientifics has 2 portfolio exits. Their latest portfolio exit was Imagion Biosystems on June 22, 2017.
Date | Exit | Companies | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Acquirer | Sources |
---|---|---|---|---|---|
6/22/2017 | IPO | Public | 1 | ||
Date | 6/22/2017 | |
---|---|---|
Exit | IPO | |
Companies | ||
Valuation | ||
Acquirer | Public | |
Sources | 1 |
Manhattan Scientifics Acquisitions
2 Acquisitions
Manhattan Scientifics acquired 2 companies. Their latest acquisition was Imagion Biosystems on June 15, 2011.
Date | Investment Stage | Companies | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Total Funding | Note | Sources |
---|---|---|---|---|---|---|
6/15/2011 | Acquired | |||||
6/13/2011 |
Date | 6/15/2011 | 6/13/2011 |
---|---|---|
Investment Stage | ||
Companies | ||
Valuation | ||
Total Funding | ||
Note | Acquired | |
Sources |
Manhattan Scientifics Partners & Customers
6 Partners and customers
Manhattan Scientifics has 6 strategic partners and customers. Manhattan Scientifics recently partnered with General Cable on July 7, 2016.
Date | Type | Business Partner | Country | News Snippet | Sources |
---|---|---|---|---|---|
7/25/2016 | Partner | United States | NEW YORK -- Manhattan Scientifics , Inc. announced today that it has signed a $ 500,000 Joint Development Agreement with General Cable . | 1 | |
7/25/2016 | Partner | ||||
11/12/2008 | Partner | ||||
7/8/2008 | Partner | ||||
3/18/2008 | Partner |
Date | 7/25/2016 | 7/25/2016 | 11/12/2008 | 7/8/2008 | 3/18/2008 |
---|---|---|---|---|---|
Type | Partner | Partner | Partner | Partner | Partner |
Business Partner | |||||
Country | United States | ||||
News Snippet | NEW YORK -- Manhattan Scientifics , Inc. announced today that it has signed a $ 500,000 Joint Development Agreement with General Cable . | ||||
Sources | 1 |
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.